Chung Yong-ji
Chung Yong‑ji | |
|---|---|
정용지 | |
| Born | February 25, 1970 |
| Education | |
| Occupation | Businessman |
| Employer | Caregen |
Chung Yong‑ji (Korean: 정용지; born February 25, 1970)[1] is a South Korean businessman.[2] The founder and CEO of the biotechnology company Caregen, Forbes estimated his net worth at US$1.1 billion in February 2023.[3]
Education
[edit]Chung attained his Bachelor of Science in Genetic Engineering from Sungkyunkwan University. He then pursued a master’s degree in biology at the University of Texas at San Antonio,[4][a] and in 1996 completed a PhD in molecular biology (animal science) at Cornell University.[5] Following that, he conducted postdoctoral research in Breast Oncology at the Northwestern University Feinberg School of Medicine from 2000 to 2001.[2]
Career
[edit]Chung founded Caregen in August 2001, focusing on peptide technology research and development.[6]
Caregen went public on the KOSDAQ in 2015, raising approximately $160 million.[3] As of late 2023, Chung holds roughly 64% of the company.[2]
Notes
[edit]- ^ other sources say Texas State University[3]
References
[edit]- ^ "주식등의 대량보유상황보고서". KOSDAQ.
- ^ a b c 김은혜 (2025-04-07). "[Who Is ?] 정용지 케어젠 대표이사". 비즈니스포스트 (in Korean). Retrieved 2025-07-01.
- ^ a b c Kang, John (February 5, 2023). "South Korean Founder Of Anti-Wrinkle Shot-Maker Becomes A Billionaire". Forbes. Retrieved 2025-07-01.
- ^ "Yong-Ji Chung - 214370.KR | Caregen Co. Ltd. - Wall Street Journal". www.wsj.com. Retrieved 2025-07-01.
- ^ Kang, John (January 21, 2024). "Little-Known Biotech Company Shows How Hard It Is To Ride The Ozempic Wave". Forbes. Retrieved 2025-07-01.
- ^ 이민주, 전문기자 (February 12, 2018). "[CEO to CEO] "시장과 소비자에 답 있다" 정용지 케어젠 대표". 뉴스핌.